Nkarta, Inc. Debt Securities, Available-for-sale, Current
Nkarta, Inc. (NKTX) had Debt Securities, Available-for-sale, Current of $314.65 million as of 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2023-03-16
- 2022-12-31: Debt Securities, Available-for-sale, Current $314.65M.
- 2022-09-30: Debt Securities, Available-for-sale, Current $352.70M.
- 2022-06-30: Debt Securities, Available-for-sale, Current $281.31M.
- 2022-03-31: Debt Securities, Available-for-sale, Current $175.35M.
| Period end | Debt Securities, Available-for-sale, Current | Debt Securities, Available-for-sale, Current as first filed |
|---|---|---|
| 2022-12-31 | $314.65M 10-K · filed 2023-03-16 | |
| 2022-09-30 | $352.70M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $281.31M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $175.35M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $177.27M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $161.48M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $255.38M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $236.66M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $218.22M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $141.19M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.90M 10-Q · filed 2020-08-20 | |
| 2019-12-31 | $16.38M 10-K · filed 2021-03-25 | $16.38M 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |